Schafer Cullen Capital Management Inc. increased its position in Roche Holding Ltd. (NASDAQ:RHHBY) by 10.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,369,119 shares of the company’s stock after buying an additional 230,620 shares during the period. Schafer Cullen Capital Management Inc.’s holdings in Roche Holding were worth $75,883,000 as of its most recent filing with the SEC.

A number of other institutional investors also recently modified their holdings of the company. S&T Bank PA acquired a new position in Roche Holding during the fourth quarter worth about $141,000. Mechanics Bank Trust Department acquired a new position in Roche Holding during the first quarter worth about $217,000. Delaney Dennis R increased its position in Roche Holding by 18.3% in the third quarter. Delaney Dennis R now owns 7,305 shares of the company’s stock worth $227,000 after buying an additional 1,130 shares in the last quarter. Cadence Bank NA increased its position in Roche Holding by 11.5% in the fourth quarter. Cadence Bank NA now owns 8,718 shares of the company’s stock worth $249,000 after buying an additional 901 shares in the last quarter. Finally, Moloney Securities Asset Management LLC acquired a new position in Roche Holding during the fourth quarter worth about $258,000.

Institutional Ownership by Quarter for Roche Holding (NASDAQ:RHHBY)

Roche Holding Ltd. (NASDAQ:RHHBY) traded up 1.80% on Friday, hitting $32.81. 878,316 shares of the company’s stock were exchanged. The company has a market cap of $223.62 billion and a PE ratio of 23.09. Roche Holding Ltd. has a 12-month low of $25.25 and a 12-month high of $36.82. The company’s 50-day moving average price is $33.42 and its 200-day moving average price is $31.06.

COPYRIGHT VIOLATION WARNING: “Roche Holding Ltd. (RHHBY) Shares Bought by Schafer Cullen Capital Management Inc.” was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this story on another domain, it was stolen and republished in violation of United States & international copyright & trademark laws. The correct version of this story can be accessed at https://www.thecerbatgem.com/2017/06/16/schafer-cullen-capital-management-inc-acquires-230620-shares-of-roche-holding-ltd-rhhby-updated-updated.html.

A number of equities analysts have recently issued reports on RHHBY shares. Jefferies Group LLC reiterated a “buy” rating on shares of Roche Holding in a research note on Sunday, February 19th. Barclays PLC started coverage on shares of Roche Holding in a research note on Tuesday, March 7th. They issued an “overweight” rating for the company. Liberum Capital started coverage on shares of Roche Holding in a research note on Thursday, March 9th. They issued a “hold” rating for the company. Zacks Investment Research upgraded shares of Roche Holding from a “hold” rating to a “buy” rating and set a $36.00 target price for the company in a research note on Tuesday, March 28th. Finally, Cowen and Company upgraded shares of Roche Holding from a “market perform” rating to an “outperform” rating and raised their target price for the company from $25.25 to $33.37 in a research note on Wednesday, April 5th. One research analyst has rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the stock. Roche Holding presently has an average rating of “Buy” and an average target price of $34.69.

About Roche Holding

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Receive News & Stock Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related stocks with our FREE daily email newsletter.